Genetic Signatures Adds Former CEO to Board as BCAL Questions Merger [VIDEO]
Dr John Melki is back on the GSS Board, but BCAL's fight over the 40/60 Genetic Signatures Microba merger split is far from settled ahead of the 16 November AGM.
Key Takeaways
- Shareholders approved former CEO Dr John Melki to the GSS Board on 28 October 2026, but the other three BCAL-requisitioned resolutions failed.
- Under the revised Genetic Signatures Microba merger terms, GSS holders would own 40% of the combined company against 60% for Microba holders.
- BCAL says the expert report in the addendum covers only Microba shareholders and option holders and will arrive after GSS shareholders vote.
- BCAL wants a breakdown of the $1.5 million estimated transaction costs, including what GSS bears if the scheme is not implemented.
- The GSS AGM on 16 November is the next key date, with the scheme booklet and Scheme Implementation Deed execution to follow, undated.
![Immuron Posts $2.2M Q1 FY27 Sales as Travelan Relaunch Lifts Australia 14% [VIDEO]](https://media.stockwirex.com/Pharmacy-Display.jpg)
![Aland Equity Group Breaks Ground on 107-Villa Seniors Estate as Builders Line Up [VIDEO]](https://media.stockwirex.com/Construction-Site-Signage.jpg)
![Imugene Reports New Complete and Partial Responses in CAR T Trial [VIDEO]](https://media.stockwirex.com/Futuristic-Laboratory-Design.jpg)
Breaking ASX Alerts Direct to Your Inbox
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
- Breaking ASX announcements delivered within minutes
- Alerts delivered with expert analysis
- Optional text alert for subscribers
- No spam policy, unsubscribe any time
About the Publisher
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
Disclaimer
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X Pty Ltd (CAR No. 001 322 642) is a Corporate Authorised Representative of ShareX Pty Ltd (AFSL No. 519872), regulated by the Australian Securities and Investments Commission (ASIC). StockWire X is authorised to provide general financial product advice in relation to basic deposit products, securities, and managed investment schemes.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
Disclosure
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
Disclaimer